Literature DB >> 3294176

Sexual dysfunction in hypertensive men. A critical review of the literature.

S Bansal1.   

Abstract

Sexual dysfunction is common in hypertensive men and often is first reported by patients while receiving hypotensive therapy, leading to a widespread belief by patients and physicians that the sexual dysfunction is caused by a specific antihypertensive medication. However, it is unclear from the literature whether this problem is related to hypertension or to its therapy. Further, whether the erectile failures reported during therapy are a result of 1) reduced penile blood flow secondary to reduction of blood pressure after antihypertensive treatment or to obstructive vascular disease (or both) or 2) specific drug effects has not been well studied. Because of these unresolved issues, this common problem is not well managed and contributes to noncompliance with therapy by hypertensive male patients, which impedes the attainment of satisfactory blood pressure control. The present article reviews the literature related to hypertension and sexual function in men and outlines a management strategy for clinicians that attempts to document normalcy of sexual function before initiating treatment in newly diagnosed hypertensive patients. Further, it does not ascribe causality to specific antihypertensive agents for the sexual dysfunction reported by treated hypertensive patients but attempts instead to delineate the pathogenesis of the dysfunction. Once the pathogenesis is established, treatment plans can be implemented to restore normotension and maintain adequate sexual function among treated hypertensive men. The article also discusses how applied research in this area may be performed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294176     DOI: 10.1161/01.hyp.12.1.1

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

1.  Aspects of quality of life on treatment with felodipine.

Authors:  E Dimenäs; M A Wallander; K Svärdsudd; I Wiklund
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  The penis as a barometer of endothelial health.

Authors:  Andrew R McCullough
Journal:  Rev Urol       Date:  2003

Review 3.  Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs.

Authors:  Rainer Düsing
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Sexual activity and ischemic heart disease.

Authors:  Richard A Lange; Glenn N Levine
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

Review 5.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 6.  Effects of antihypertensive therapy on sexual activity in hypertensive men.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 7.  Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease.

Authors:  R W Jansen; J H Gurwitz
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

8.  Erectile dysfunction and its management in patients with diabetes mellitus.

Authors:  Giuseppe Defeudis; Daniele Gianfrilli; Chiara Di Emidio; Riccardo Pofi; Dario Tuccinardi; Andrea Palermo; Andrea Lenzi; Paolo Pozzilli
Journal:  Rev Endocr Metab Disord       Date:  2015-10-26       Impact factor: 6.514

Review 9.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

10.  A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction.

Authors:  George F Lasker; Jason H Maley; Philip J Kadowitz
Journal:  Adv Pharmacol Sci       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.